TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/24 20:12 | 9/16/24 | MBX | Mbx Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 17, L.P. | MD | T | P.d | 8,000 | 16.00 | 0 | 500 | 16 | 3,614 | D | |||||||||||||||
4/24/24 17:00 | 4/22/24 | KRRO | Korro Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 17, L.P. | MD | T | P | 1,000 | 56.00 | 0 | 18 | 2 | 1,091 | D | |||||||||||||||
6/30/21 17:59 | 6/28/21 | GLUE | Monte Rosa Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | New Enterprise Associates 17, L.P. | MD | T | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |